On 12 November 2014, after a 10-year journey through the solar system and over 500 million kilometers from home, Rosetta's lander Philae made space exploration history by touching down on a comet for ...
2. The implant is reabsorbed and replaced by the patient's bone and lets Citrepore guide healing metabolically. 3. Citrepore has more than 80% porosity and is osteoconductive and bioactive. 4. The ...
Acuitive Technologies, Inc. today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market CITREPORE, a unique synthetic bioactive bone void filler, using ...